New report on PrEP in Scotland

Back to news & events

Tuesday 8th March 2016

Pre-Exposure Prophylaxis, or PrEP, is an HIV prevention strategy using antiretroviral (ARV) drugs to protect HIV negative people from HIV infection.

This report [PDF - 7MB] sets out the background and evidence for PrEP, while also providing a Scottish context and answering key questions. It also outlines recommendations for what needs to happen now, and in the future to ensure safe and effective use of PrEP in Scotland. This report has been developed through research, ongoing consultation with key stakeholders and community, and through the views of participants at a roundtable on PrEP hosted by HIV Scotland in 2015.

The key recommendations include:

  • PrEP should be made available to high risk MSM in areas of high prevalence as a matter of priority, in accordance with existing evidence on cost and clinical effectiveness.
  • Sexual health services must be equipped to provide support and monitoring to people using PrEP now and in the future, including appropriate testing and advice. This will require the urgent development of guidance and training for staff to ensure a consistent and quality approach across Scotland.
  • HIV Executive Leads, HIV Clinical Leads Group and Scottish Sexual Health Lead Clinicians should ensure the development of a consensus statement setting out a recommended prescribing criteria for PrEP (including when it may or may not be appropriate to prescribe ‘off-label’), with related guidance as to how to prescribe PrEP safely.
  • PrEP should be promoted as part of a combination prevention package and should be used in conjunction with additional either biomedical or behavioural interventions.

If you have any questions, comments or would like to discuss the report further please contact us .